A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

• University of Ibadan (NG)

• University of Ibadan (NG)

• Olabisi Onabanjo University Teaching Hospital (NG)

• University of Ibadan (NG)

tal como impresso: Adeniyi F. Fagbamigbe

• Obafemi Awolowo University (NG)

tal como impresso: Babatunde A. Adeagbo

• Olabisi Onabanjo University Teaching Hospital (NG)

tal como impresso: Bolanle O. Adefuye

• Obafemi Awolowo University Teaching Hospitals Complex (NG)
• Obafemi Awolowo University (NG)

tal como impresso: Temitope O. Ojo

• University of Ibadan (NG)

tal como impresso: Akindele O. Adebiyi

• Nigeria Centre for Disease Control (NG)

• Federal College of Forestry, Ibadan (NG)

• Obafemi Awolowo University (NG)

• Obafemi Awolowo University Teaching Hospitals Complex (NG)
• Obafemi Awolowo University (NG)

• Obafemi Awolowo University (NG)

tal como impresso: Steve Rannard

• Redeemer's University (NG)